Thermally treated kaolin as an extender pigment
Journal of Materials Science Letters, 1990On a cherche a ameliorer les performances du kaolin dans les peintures a l'aide d'un traitement thermique de deshydroxylation. On examine les proprietes physiques et optiques du kaolin avant et apres calcination et les proprietes optiques de peintures obtenues a partir de plusieurs formulations.
S. Ghosh +2 more
openaire +1 more source
TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION
Retina, 2016To evaluate the effects of aflibercept therapy using a treat-and-extend regimen on treatment-naïve retinal angiomatous proliferation (RAP) and development of retinal pigment epithelium (RPE) atrophy.We retrospectively studied 17 treated eyes with RAP and 13 untreated fellow eyes.
Hidetaka, Matsumoto +9 more
openaire +2 more sources
Conservatively Treated Extended Tracheal Necrosis Complicating Pharyngolaryngectomy
The Annals of Thoracic Surgery, 2015Tracheal necrosis is a rare life-threatening phenomenon that most often occurs after thyroid operations or prolonged intubation. Conservative treatment can be one choice in extensive tracheal necrosis. We report the case of a 59-year-old man, with tracheal necrosis that developed after pharyngolaryngectomy, that we treated conservatively using ...
Julien, De Wolf +4 more
openaire +2 more sources
Deep neck space infection extending to the mediastinum that was treated conservatively
BMJ Case Reports, 2022Deep neck space infections (DNSIs) are challenging to diagnose and manage. A female ex-smoker presented with difficulty breathing and chest pain. She was initially treated for exacerbation of emphysema with intravenous antibiotics. The ear, nose and throat team were later asked to review the patient for left submandibular swelling and odynophagia.
Haran Devakumar +3 more
openaire +2 more sources
An Extended Lymphocytotoxicity Test for Patients Treated with Lymphocytotoxic Antibodies
Vox Sanguinis, 2000AbstractBackground and Objectives:After organ transplantation, HLA antibodies (HLA‐Ab) stimulated by transplant or transfusion are usually indistinguishable from passive therapeutic lymphocytotoxic antibodies (LyAb), e.g. antilymphocyte globulin (ALG), antithymocyte globulin (ATG) and OKT3, by standard lymphocytotoxicity tests (LCTs).
A, Moldenhauer, R, Kohlhaus, A, Salama
openaire +2 more sources
Changes of Plasma Fibronectin in Patients Treated with Cryofiltration for an Extended Period
Therapeutic Apheresis, 1999Abstract: The purpose of this study was to evaluate correlations between extra domain A fibronectin (EDA[+]FN) in plasma and the clinical course in cryofiltration for an extended period. Two patients with systemic lupus erythematosus (SLE), 1 with aortitis syndrome, 1 with ankylosis spondylitis, 1 with polymyositis, 1 with rheumatoid arthritis, and 1 ...
M, Yonekawa +5 more
openaire +2 more sources
Giant ancient schwannoma of pancreatic head treated by extended pancreatoduodenectomy
Pancreatology, 2004We report a case of a 55-year-old woman who was transferred from another center to our university clinic after diagnostic laparotomy with a pancreatic head tumor which was seen to encase the portal vein. Although intraoperative biopsies were performed, a histologic diagnosis of the tumor was not possible before giving suspect to a malignant tumor being
Dobschütz, Ernst von +4 more
openaire +3 more sources
Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies
Clinical Lymphoma Myeloma and Leukemia, 2017Bendamustine, typically in combination with rituximab, is an effective treatment for chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin lymphoma. Despite its acceptable short-term toxicity profile, long-term toxicities are less well established.
Mara, Penne +3 more
openaire +2 more sources
Efficacy of levomilnacipran extended release in treating major depressive disorder
Expert Opinion on Pharmacotherapy, 2017Major depressive disorder (MDD) is the leading cause of disability worldwide with a heterogeneous symptom profile. Levomilnacipran extended release (ER) (Fetzima), a SNRI, has been approved by the Food and Drug Administration for treatment of MDD.
Renee-Marie, Ragguett +3 more
openaire +2 more sources
Treat and extend versus PRN in diabetic retinopathy
Acta Ophthalmologica, 2016SummaryVascular endothelial growth factor (VEGF) plays a key role in the pathogenesis of the neo‐vascular age related macular degeneration (nAMD) and the ischemic retinal microangiopathies. Targeting VEGF in retinal diseases became an effective therapeutic option.To optimize the benefit of risk ratio and cost effectiveness of anti‐VEGF agents, a number
openaire +1 more source

